Evaluation of selective COX-2 inhibitor for the protection of intestinal mucosal damage in comparison to NSAID in patients with rheumatoid arthritis (Investigation by capsule endoscopy and measurement of biomarkers for rheumatoid arthritis).
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Celecoxib (Primary)
- Indications Musculoskeletal pain; Rheumatoid arthritis
- Focus Adverse reactions; Biomarker
Most Recent Events
- 28 Sep 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 07 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 03 Oct 2009 New trial record